FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214721878> ?p ?o ?g. }

• W4214721878 endingPage "17" @default.
• W4214721878 startingPage "1" @default.
• W4214721878 abstract "MFAP2 has been reported to play an oncogenic role in several types of human cancers. However, the expression profile of MFAP2 in various cancers and its impact on prognosis and immune infiltration remain unclear. In this study, the mRNA expression and protein expression of MFAP2 in normal tissues, tumor cell lines, and 33 malignant tumor tissues were analyzed comprehensively using Genotype-Tissue Expression (GTEx), Cancer Cell Line Encyclopedia (CCLE), and The Cancer Genome Atlas (TCGA), Oncomine and UALCAN databases, and the expression of MFAP2 in different grades and stages of cancers was assessed using Gene Expression Profiling Interactive Analysis 2 (GEPIA2) and Tumor and Immune System Interaction Database (TISIDB). In general, MFAP2 showed distinct expression in most tumor and normal tissues, closely associated with higher tumor grade, higher tumor stage, and poor survival in multiple cancers. A search of the UALCAN database and the cBioPortal database revealed that this difference in mRNA level expression could be partly attributed to abnormal DNA methylation and mutations at the genomic level. In addition, MFAP2 expression was also associated with tumor mutation burden, microsatellite instability, and neoantigens in different cancer types. More importantly, the TIMER and TISIDB databases also showed that MFAP2 levels were significantly correlated with immune infiltration abundance and immune-related gene markers, as well as ESTIMATE scores. By qPCR, MFAP2 expression was validated in four kinds of tumor tissue samples. The present study combined several databases and performed a pan-cancer analysis of the expression profile, methylation, and mutation for MFAP2 and its implications for prognosis and immune infiltration, suggesting that MFAP2 could contribute to malignant properties of many tumors. MFAP2 may be an important biomarker with prognostic value and has the potential to be a target for tumor immunotherapy." @default.
• W4214721878 created "2022-03-02" @default.
• W4214721878 creator A5008465504 @default.
• W4214721878 creator A5023602564 @default.
• W4214721878 creator A5033044099 @default.
• W4214721878 creator A5055528381 @default.
• W4214721878 creator A5062485473 @default.
• W4214721878 creator A5066252438 @default.
• W4214721878 date "2022-02-15" @default.
• W4214721878 modified "2023-09-30" @default.
• W4214721878 title "Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification" @default.
• W4214721878 cites W181486121 @default.
• W4214721878 cites W1861274688 @default.
• W4214721878 cites W2011182234 @default.
• W4214721878 cites W2082668371 @default.
• W4214721878 cites W2118549356 @default.
• W4214721878 cites W2124295966 @default.
• W4214721878 cites W2149441684 @default.
• W4214721878 cites W2156253417 @default.
• W4214721878 cites W2314057593 @default.
• W4214721878 cites W2407062242 @default.
• W4214721878 cites W2472617159 @default.
• W4214721878 cites W2739132742 @default.
• W4214721878 cites W2767034994 @default.
• W4214721878 cites W2791605773 @default.
• W4214721878 cites W2830504944 @default.
• W4214721878 cites W2904370205 @default.
• W4214721878 cites W2931898983 @default.
• W4214721878 cites W2953390364 @default.
• W4214721878 cites W2972600793 @default.
• W4214721878 cites W2972700532 @default.
• W4214721878 cites W2986629061 @default.
• W4214721878 cites W2995684511 @default.
• W4214721878 cites W2997965122 @default.
• W4214721878 cites W3000630873 @default.
• W4214721878 cites W3002573892 @default.
• W4214721878 cites W3006331432 @default.
• W4214721878 cites W3031935947 @default.
• W4214721878 cites W3035897172 @default.
• W4214721878 cites W3048398491 @default.
• W4214721878 cites W3092496866 @default.
• W4214721878 cites W3109041010 @default.
• W4214721878 cites W3112559080 @default.
• W4214721878 cites W3112893878 @default.
• W4214721878 cites W3126206495 @default.
• W4214721878 cites W3133198879 @default.
• W4214721878 cites W3137977993 @default.
• W4214721878 doi "https://doi.org/10.1155/2022/8423173" @default.
• W4214721878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35211173" @default.
• W4214721878 hasPublicationYear "2022" @default.
• W4214721878 type Work @default.
• W4214721878 citedByCount "3" @default.
• W4214721878 countsByYear W42147218782022 @default.
• W4214721878 countsByYear W42147218782023 @default.
• W4214721878 crossrefType "journal-article" @default.
• W4214721878 hasAuthorship W4214721878A5008465504 @default.
• W4214721878 hasAuthorship W4214721878A5023602564 @default.
• W4214721878 hasAuthorship W4214721878A5033044099 @default.
• W4214721878 hasAuthorship W4214721878A5055528381 @default.
• W4214721878 hasAuthorship W4214721878A5062485473 @default.
• W4214721878 hasAuthorship W4214721878A5066252438 @default.
• W4214721878 hasBestOaLocation W42147218781 @default.
• W4214721878 hasConcept C104317684 @default.
• W4214721878 hasConcept C121608353 @default.
• W4214721878 hasConcept C150194340 @default.
• W4214721878 hasConcept C158163496 @default.
• W4214721878 hasConcept C180754005 @default.
• W4214721878 hasConcept C18431079 @default.
• W4214721878 hasConcept C190727270 @default.
• W4214721878 hasConcept C203014093 @default.
• W4214721878 hasConcept C2779767149 @default.
• W4214721878 hasConcept C33288867 @default.
• W4214721878 hasConcept C41008148 @default.
• W4214721878 hasConcept C502942594 @default.
• W4214721878 hasConcept C54355233 @default.
• W4214721878 hasConcept C61320498 @default.
• W4214721878 hasConcept C6856738 @default.
• W4214721878 hasConcept C71924100 @default.
• W4214721878 hasConcept C77088390 @default.
• W4214721878 hasConcept C86803240 @default.
• W4214721878 hasConcept C8891405 @default.
• W4214721878 hasConceptScore W4214721878C104317684 @default.
• W4214721878 hasConceptScore W4214721878C121608353 @default.
• W4214721878 hasConceptScore W4214721878C150194340 @default.
• W4214721878 hasConceptScore W4214721878C158163496 @default.
• W4214721878 hasConceptScore W4214721878C180754005 @default.
• W4214721878 hasConceptScore W4214721878C18431079 @default.
• W4214721878 hasConceptScore W4214721878C190727270 @default.
• W4214721878 hasConceptScore W4214721878C203014093 @default.
• W4214721878 hasConceptScore W4214721878C2779767149 @default.
• W4214721878 hasConceptScore W4214721878C33288867 @default.
• W4214721878 hasConceptScore W4214721878C41008148 @default.
• W4214721878 hasConceptScore W4214721878C502942594 @default.
• W4214721878 hasConceptScore W4214721878C54355233 @default.
• W4214721878 hasConceptScore W4214721878C61320498 @default.
• W4214721878 hasConceptScore W4214721878C6856738 @default.
• W4214721878 hasConceptScore W4214721878C71924100 @default.
• W4214721878 hasConceptScore W4214721878C77088390 @default.

• next